These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35018213)

  • 1. Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study.
    Murewanhema G; Burukai TV; Chireka B; Kunonga E
    Pan Afr Med J; 2021; 40():180. PubMed ID: 35018213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of COVID-19 vaccination hesitancy among healthcare workers in Sub-Saharan Africa: A systematic review and meta-analysis.
    Kigongo E; Kabunga A; Tumwesigye R; Musinguzi M; Izaruku R; Acup W
    PLoS One; 2023; 18(7):e0289295. PubMed ID: 37506132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers.
    Miner CA; Timothy CG; Percy K; Mashige ; Osuagwu UL; Envuladu EA; Amiebenomo OM; Ovenseri-Ogbomo G; Charwe DD; Goson PC; Ekpenyong BN; Abu EK; Langsi R; Oloruntoba R; Ishaya T; Agho KE
    BMC Public Health; 2023 Jan; 23(1):191. PubMed ID: 36709269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccine Hesitancy in South Africa: Lessons for Future Pandemics.
    Engelbrecht M; Heunis C; Kigozi G
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining trends in vaccine confidence across sub-Saharan Africa: A large-scale cross-sectional modeling study.
    de Figueiredo A; Temfack E; Tajudeen R; Larson HJ
    Hum Vaccin Immunother; 2023 Dec; 19(1):2213117. PubMed ID: 37290478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing COVID-19 vaccine hesitancy and barriers to uptake in Sub-Saharan Africa.
    Wollburg P; Markhof Y; Kanyanda S; Zezza A
    Commun Med (Lond); 2023 Sep; 3(1):121. PubMed ID: 37696937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.
    Kouamou V; Matarise R; Santos ED; Elose N; Manasa J
    Pan Afr Med J; 2021; 39():255. PubMed ID: 34707756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance of COVID-19 vaccines in sub-Saharan Africa: evidence from six national phone surveys.
    Kanyanda S; Markhof Y; Wollburg P; Zezza A
    BMJ Open; 2021 Dec; 11(12):e055159. PubMed ID: 34911723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impacts of COVID-19 vaccination programme's timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries.
    Liu Y; Procter SR; Pearson CAB; Montero AM; Torres-Rueda S; Asfaw E; Uzochukwu B; Drake T; Bergren E; Eggo RM; Ruiz F; Ndembi N; Nonvignon J; Jit M; Vassall A
    BMC Med; 2023 Mar; 21(1):85. PubMed ID: 36882868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach.
    Osuagwu UL; Langsi R; Ovenseri-Ogbomo G; Mashige KP; Abu EK; Envuladu EA; Goson PC; Ekpenyong BN; Oloruntoba R; Miner CA; Charwe DD; Timothy CG; Ishaya T; Amiebenomo OM; Lim D; Agho KE
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. South African University Staff and Students' Perspectives, Preferences, and Drivers of Hesitancy Regarding COVID-19 Vaccines: A Multi-Methods Study.
    George G; Strauss M; Lansdell E; Nadesan-Reddy N; Moroe N; Reddy T; Eshun-Wilsonova I; Moshabela M
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.
    Williams V; Edem B; Calnan M; Otwombe K; Okeahalam C
    Emerg Infect Dis; 2021 Aug; 27(8):2009-2016. PubMed ID: 34138694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in COVID-19 vaccination intent among South African adults: evidence from the NIDS-CRAM panel survey, February to May 2021.
    Burger R; Köhler T; Golos AM; Buttenheim AM; English R; Tameris M; Maughan-Brown B
    BMC Public Health; 2022 Mar; 22(1):422. PubMed ID: 35236319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review.
    Deml MJ; Githaiga JN
    BMJ Open; 2022 Nov; 12(11):e066615. PubMed ID: 36400736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Qualitative Study Exploring Motivators and Barriers to COVID-19 Vaccine Uptake among Adults in South Africa and Zimbabwe.
    Myburgh N; Mulaudzi M; Tshabalala G; Beta N; Gutu K; Vermaak S; Lau C; Hill C; Stanberry L; James W; Madhi S; Makadzange T; Dietrich JJ
    Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among adult population: qualitative analysis across six different states of India.
    Godbole S; Diwan V; Das S; Reddy MM; Kalyanasundaram M; Rajendran D; Biswas D; Mamulwar M; Tiwari RR; Majumder J; Mishra A; Muthusamy SK; Memeenao M; Gupta N; Gupta S; George LS; Kadale P; Trushna T; Saha I; Alam U; Kathiresan J; Phukan SK; Sane S; Bhowmik K; Yadav GK; Krishnamurthy V; Gogoi P; Padhye K; Kant R; Ghosh P; Kharat M; Kulkarni A
    Front Public Health; 2023; 11():1293600. PubMed ID: 38328539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Learn from the lessons and don't forget them': identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns.
    Collins J; Westerveld R; Nelson KA; Rohan H; Bower H; Lazenby S; Ikilezi G; Bartlein R; Bausch DG; Kennedy DS
    BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34535490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.